US Patent 10988547 Bi-specific fusion proteins
Patent 10988547 was granted and assigned to Silver Creek Pharmaceuticals, Inc. on April, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10988547 Bi-specific fusion proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.